Operationalisation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 trials in a low and lower-middle income critical care learning health system
The Randomized Embedded Multifactorial Adaptive Platform (REMAP-CAP) adapted for COVID-19) trial is a global adaptive platform trial of hospitalised patients with COVID-19. We describe implementation in three countries under the umbrella of the Wellcome supported Low and Middle Income Country (LMIC)...
Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
F1000 Research
2021
|